medroxyprogesterone acetate has been researched along with Lymph Node Metastasis in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (32.26) | 18.7374 |
1990's | 11 (35.48) | 18.2507 |
2000's | 9 (29.03) | 29.6817 |
2010's | 1 (3.23) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanprasertpong, J; Manusirivithaya, S; Tangjitgamol, S | 1 |
Anderson, GL; Aragaki, AK; Chlebowski, RT; Gass, M; Hendrix, SL; Johnson, KC; Kuller, LH; Lane, DS; Manson, JE; Ockene, J; Prentice, RL; Rajkovic, A; Ravdin, PM; Rohan, TE; Sarto, GE; Schenken, R; Stefanick, ML; Wactawski-Wende, J; Yasmeen, S | 1 |
Fukushima, M; Ono, Y; Sawada, M | 1 |
Okazaki, Y; Yamada, T; Yuyama, Y | 1 |
Kihara, M; Kontani, K; Yamauchi, A; Yokomise, H | 1 |
Baltar Arias, R; Castro Ortiz, E; Fernández Salgado, E; Ibáñez Pinto, A; Ledo Barro, L; Vázquez Astray, E; Vázquez San Luis, J; Vázquez Vázquez, S | 1 |
Harashima, S; Hirashima, Y; Ito, I; Kawaguchi, R; Takahashi, N; Takekuma, M; Yamada, Y | 1 |
Belnome, N; Calbo, L; Di Mauro, S; Melita, P; Navarra, S | 1 |
Asaishi, K; Hirata, K; Masuoka, H; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Toda, K; Yamada, T | 1 |
Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Ferri, L; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Omodei Zorini, C | 1 |
Dohi, K; Gotoh, T; Kataoka, T; Nishiki, M; Okamoto, T; Sadamoto, S | 1 |
Bron, H; de Jong, J; Fickers, M; Hupperets, PS; Jager, J; Schouten, HC; Schouten, L; Smeets, J; Volovics, L; Wils, J | 1 |
Ansai, Y; Fujimaki, M; Hino, K; Karaki, Y; Shimada, K; Yamashita, Y | 1 |
Egami, T; Ikeda, S; Kuroda, Y; Mitsuyama, S; Mori, A; Murakami, F; Nakamura, Y; Nishikata, F; Ohe, H; Ohsato, K | 1 |
Kuribayashi, H; Nishibe, M; Nishihara, H; Sato, T; Watanabe, I | 1 |
Fujii, T; Kanno, K; Ogata, T; Roppongi, T; Yokota, T | 1 |
Kihara, M; Maeda, M; Matsusaka, K; Miyauchi, A | 1 |
Blijham, GH; de Jong, JM; Hupperets, PS; Jager, JJ; Schouten, LJ; Schutte, B; Volovics, L; von Meyenfeldt, MF | 1 |
Kunisue, H; Kurebayashi, J; Shimozuma, K; Sonoo, H; Tanaka, K; Udagawa, K; Yamamoto, S; Yamamoto, Y | 1 |
Baumann, P; Deppe, G; Munkarah, A | 1 |
Ino, H; Kanaya, Y; Kawasaki, K; Maruyama, S; Okumoto, T; Otani, J; Soda, M; Yokoyama, N | 1 |
Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K | 1 |
Aoki, T; Ishikawa, M; Kakuta, T; Kimura, K; Kusama, M; Suzuki, K; Yoshimatsu, A | 1 |
Bobrov, IuF; Bokhman, IaV; Fel'dkoren, BI; Tsyrlina, EV; Vishnevskiĭ, AS | 1 |
Hirai, T; Iino, Y; Ishida, T; Izuo, M; Kawai, T; Ogawa, T; Suzuki, H; Yokoe, T | 1 |
Bonte, J; Ide, P; Janssens, JP | 1 |
Jonat, W; Maass, H | 1 |
Alford, WM; Ehrlich, CE; Stehman, FB; Sutton, GP; Young, PC | 1 |
Debruyne, FM | 1 |
Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G | 1 |
Amin, R | 1 |
2 review(s) available for medroxyprogesterone acetate and Lymph Node Metastasis
Article | Year |
---|---|
[Gastrointestinal bleeding of obscure origin caused by a metastatic endometrial adenocarcinoma. Response to hormonal therapy].
Topics: Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Pelvic Neoplasms; Peritoneal Neoplasms; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Umbilicus | 2007 |
[Chemotherapy in metastatic or recurrent endometrial carcinoma].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Endometrial Neoplasms; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant | 2000 |
7 trial(s) available for medroxyprogesterone acetate and Lymph Node Metastasis
Article | Year |
---|---|
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
Topics: Aged; Breast Neoplasms; Drug Combinations; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Incidence; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Postmenopause; Prognosis; United States | 2010 |
[Intra-arterial infusion chemotherapy for advanced or recurrent breast cancers].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction | 1995 |
[2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Time Factors | 1994 |
Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Survival Rate | 1993 |
[Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Hydrocortisone; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Postoperative Care; Tamoxifen | 1996 |
Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; DNA, Neoplasm; Female; Flow Cytometry; Follow-Up Studies; Forecasting; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Ploidies; Prognosis; Proportional Hazards Models; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; S Phase; Thorax | 1999 |
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Topics: Aged; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Orchiectomy; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
22 other study(ies) available for medroxyprogesterone acetate and Lymph Node Metastasis
Article | Year |
---|---|
Fertility-sparing in endometrial cancer.
Topics: Adult; Algorithms; Biopsy; Cervix Uteri; Curettage; Endometrial Neoplasms; Female; Humans; Infertility, Female; Lymphatic Metastasis; MEDLINE; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Ploidies; Progesterone; Prognosis | 2009 |
[A case of advanced recurrent breast cancer responding to treatment with weekly docetaxel combined with doxorubicin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Humans; Lung Neoplasms; Lymphatic Metastasis; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Middle Aged; Paclitaxel; Skin Neoplasms; Taxoids | 2003 |
[A long-surviving patient with Stage IV breast cancer with no recurrence after combined therapy of medroxy progesterone acetate (MPA) and intra-arterial infusion chemotherapy].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Epirubicin; Female; Floxuridine; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Mastectomy, Segmental; Medroxyprogesterone Acetate; Neoplasm Staging; Survivors; Tamoxifen | 2004 |
[Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged | 2005 |
A patient with stage 1a endometrial carcinoma in whom a solitary recurrent lesion was detected in the external iliac lymph node after MPA therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Positron-Emission Tomography; Sentinel Lymph Node Biopsy | 2008 |
[Hormone treatment of metastasizing breast carcinoma].
Topics: Bone Neoplasms; Breast Neoplasms; Castration; Estradiol Congeners; Humans; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Progesterone Congeners; Tamoxifen; Testosterone Congeners | 1981 |
[A case of breast cancer with multiple organ metastases in which single low dose administration of 5'-DFUR proved effective].
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Lymphatic Metastasis; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prognosis; Quality of Life; Tamoxifen | 1993 |
[A case of breast cancer with metastasis of multiple organs showing marked efficacy of medroxyprogesterone acetate (MPA)].
Topics: Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Pleural Neoplasms; Remission Induction | 1996 |
[A case of advanced breast cancer receiving combination therapy with 5'-DFUR and MPA with remarkable results].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Drug Administration Schedule; Female; Floxuridine; Humans; Lymph Node Excision; Lymphatic Metastasis; Medroxyprogesterone Acetate | 1997 |
[A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged | 1998 |
[A case of stage IV breast cancer showing long-term complete response to combination therapy with 5'-DFUR and MPA].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Floxuridine; Humans; Lymphatic Metastasis; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Remission Induction | 1998 |
[A case of advanced breast cancer associated with humoral hypercalcemia that responded to medroxyprogesterone acetate and docetaxel].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Hypercalcemia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Paclitaxel; Taxoids | 2000 |
[A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Remission Induction | 2000 |
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Remission Induction | 1991 |
[Complete remission, obtained by multidisciplinary treatment of recurrent breast cancer with carcinomatous pleuritis, and cervical lymph node and diver metastasis].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Pleurisy; Remission Induction | 1989 |
[Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents; Cytoplasm; Drug Evaluation; Female; Homeostasis; Humans; Hydroxyprogesterones; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Preoperative Care; Receptors, Cell Surface; Reproduction; Uterine Neoplasms; Vaginal Smears | 1989 |
[An analysis of treatments of recurrent breast cancer in relation to the lesion].
Topics: Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Tamoxifen | 1985 |
Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Hemorrhage; Uterine Neoplasms | 1986 |
[Endocrine therapy of breast cancer].
Topics: Aminoglutethimide; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Female; Hormones; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1987 |
Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Injections, Intramuscular; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1988 |
[Which hormone therapy should be used in advanced breast carcinoma in males?].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners | 1988 |
Complete regression of skeletal metastases from hypernephroma after angioinfarction and medroxyprogesterone acetate therapy.
Topics: Bone Neoplasms; Brain Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Renal Artery | 1988 |